Omada Health (NASDAQ:OMDA – Get Free Report) had its target price decreased by research analysts at JPMorgan Chase & Co. from $30.00 to $25.00 in a report issued on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 78.48% from the stock’s current price.
Other research analysts have also recently issued reports about the stock. Wells Fargo & Company reduced their price target on shares of Omada Health from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday, November 6th. Zacks Research cut shares of Omada Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 4th. Barclays cut their price objective on shares of Omada Health from $24.00 to $22.00 and set an “overweight” rating for the company in a research report on Friday, November 6th. BTIG Research restated a “buy” rating and set a $35.00 target price on shares of Omada Health in a research note on Friday, September 11th. Finally, Citigroup restated an “outperform” rating on shares of Omada Health in a research report on Friday, August 14th. Eleven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Omada Health has a consensus rating of “Moderate Buy” and an average price target of $25.92.
Check Out Our Latest Research Report on OMDA
Omada Health Stock Performance
Shares of Omada Health stock traded down $0.32 on Monday, hitting $14.01. The company had a trading volume of 646,792 shares, compared to its average volume of 1,272,537. The stock has a market capitalization of $868.97 million, a price-to-earnings ratio of 66.60 and a beta of 2.13. The stock has a 50 day moving average of $19.30 and a 200-day moving average of $17.71. Omada Health has a 1 year low of $10.28 and a 1 year high of $25.45.
Omada Health (NASDAQ:OMDA – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.08. Omada Health had a return on equity of 5.71% and a net margin of 4.21%. The company had revenue of $91.31 million for the quarter. Equities analysts anticipate that Omada Health will post 0.09 earnings per share for the current year.
Insider Transactions at Omada Health
In other Omada Health news, CEO Sean P. Duffy sold 21,572 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $23.62, for a total transaction of $509,530.64. Following the sale, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,728,156.82. The trade was a 4.98% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Steven L. Cook sold 6,800 shares of Omada Health stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.86, for a total value of $148,648.00. Following the sale, the chief financial officer directly owned 173,906 shares of the company’s stock, valued at $3,801,585.16. This trade represents a 3.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 79,322 shares of company stock valued at $1,720,914. Corporate insiders own 6.38% of the company’s stock.
Institutional Trading of Omada Health
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Sterling Capital Management LLC grew its position in Omada Health by 1,161.6% during the third quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock valued at $33,000 after buying an additional 1,452 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in shares of Omada Health during the 2nd quarter valued at about $53,000. State of Alaska Department of Revenue acquired a new stake in shares of Omada Health during the 3rd quarter valued at about $59,000. Versant Capital Management Inc increased its stake in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. purchased a new position in shares of Omada Health in the 3rd quarter valued at about $70,000.
About Omada Health
Omada Health is a U.S. digital health company that provides virtual care programs for people managing chronic conditions. Its services address areas including diabetes, prediabetes, hypertension, musculoskeletal conditions and weight management. The company combines digital tools, personalized health coaching and, where appropriate, clinical support to help members build health habits and manage their care. Programs may include mobile-app-based guidance and connected devices, such as scales or blood pressure monitors.
Recommended Stories
- Five stocks we like better than Omada Health
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
